2018 Conference on Retroviruses and Opportunistic Infections*

Download All
March 4-7, 2018; Boston, Massachusetts
Get up to date on the latest HIV data with rapid Capsule Summaries, downloadable slidesets, and live, expert-led Webinars covering key studies from Boston.
Chloe Orkin Photo
Chloe Orkin, MBChB, FRCP, MD

New Data from CROI 2018

Capsule Summaries ANDES: ART Initiation With DRV/RTV Plus 3TC Achieves Similar Efficacy to DRV/RTV Plus 3TC/TDF at 48 Weeks
Capsule Summaries Baseline M184V Not Associated With Increased Probability of Virologic Failure in Virologically Suppressed Italian Patients Switching to Lamivudine-Based Dual Therapy
Capsule Summaries EMERALD: Previous ARV Use and Virologic Failure Has No Impact on Efficacy of Switch From Boosted PI Plus FTC/TDF to DRV/COBI/FTC/TAF in Patients With Virologic Suppression
Capsule Summaries DAWNING: Higher Efficacy Rates With DTG + WHO-Recommended Second-line NRTIs vs LPV/RTV-Based ART
Capsule Summaries Bisphosphonate Use Results in Additional BMD Gains at Spine, but Not at Hip, in HIV-Infected Patients With Low BMD Switching From TDF- to TAF-Containing ART
Capsule Summaries DolPHIN-1 Interim Analysis: Dolutegravir-Based Regimen Appears Sufficient at Standard Dose for Women With HIV Starting ART in Third Trimester
Capsule Summaries Study 380-1844: Switch From DTG/ABC/3TC to BIC/FTC/TAF Noninferior to Continued DTG/ABC/3TC at Week 48 in Virologically Suppressed Adults
Capsule Summaries Phylogenetic Analysis Identifies Clusters of HIV-Infected Persons With High Transmission Rates
Capsule Summaries D:A:D Study: Development of Chronic Kidney Disease Increases Risk of Serious Clinical Events and Death in Patients With HIV
Capsule Summaries Substudy of Study 1717: Platelet Reactivity to Collagen Decreases After Switch From ABC/3TC-Containing to TAF/FTC-Containing ART

In this downloadable audio of a live Webinar, Chloe Orkin, MBChB, FRCP, MD, provides a rapid update on the clinical impact of new data reported at the Boston meeting.

Chloe Orkin Photo Chloe Orkin, MBChB, FRCP, MD Released: April 16, 2018

Expert faculty members summarize key studies from this important annual conference.

Released: March 2, 2018
Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC.
ACHS Logo
Contact Info

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Melissa Velasquez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/

Educational grant provided by:
Gilead Sciences
Janssen Therapeutics
ViiV Healthcare

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue